Spot the difference. It’s subtle but perhaps meaningful. I wonder why?
3rd Dec: “Starpharma continues to advance its discussions with potential commercial partners elsewhere in multiple countries in Europe, Asia, the Middle East, and India.”
16th Dec: “Starpharma is advancing negotiations with a local distributor in Saudi Arabia and the GCC region for VIRALEZETM, in addition to commercial discussions for distribution in Europe, Asia, and other regions. The product is available in certain markets online.”
It’s the first time that Jackie hasn’t specifically mentioned India (in advanced negotiations) when talking about current Viraleze commercial discussions…..
Ann: Shareholder Newsletter, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
